Bill
S 984
Overview: S 984, Establishes the first responder epinephrine preparedness initiative (EPI) act, REFERRED TO HEALTH, Introduced on March 12, 2025.Purpose and Intent: The bill aims t
Overview: S 984, Establishes the first responder epinephrine preparedness initiative (EPI) act, REFERRED TO HEALTH, Introduced on March 12, 2025.
Purpose and Intent: The bill aims to improve emergency medical response by requiring first responder agencies to carry and administer epinephrine auto-injectors. The goal is to ensure first responders have the necessary equipment and training to provide immediate treatment for severe allergic reactions.
Key Provisions:
- Establishes the First Responder Epinephrine Preparedness Initiative (EPI) to provide grants for first responder agencies to purchase epinephrine auto-injectors
- Requires first responder agencies to carry and be trained on the use of epinephrine auto-injectors
- Directs the Department of Health and Human Services to develop guidelines for first responder epinephrine use and training
Affected Parties and Impacts:
- First responder agencies, including police, fire departments, and emergency medical services, will be required to carry and administer epinephrine
- Individuals experiencing severe allergic reactions will benefit from the improved emergency response capabilities
Procedural and Timeline Considerations:
The bill has been referred to the Senate Committee on Health, Education, Labor, and Pensions. If passed, the EPI program would be implemented within 1 year of enactment.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
